US 6,184,032 B2Granted

Identification of genes encoding cell surface antigens using CREF-Trans 6 cells

AssigneeThe Trustees of Columbia University in the City of New York

InventorPaul B. Fisher

Life of this patent

Estimating the term…

Abstract

This invention provides a CREF-Trans 6 cell line. The invention further provides CREF-Trans 6 cell lines containing DNA from an established cancer cell line or a primary tumor. This invention also provides the use of said cell lines to obtain DNA encoding a cell surface antigen associated with a neoplastic human cell line.

Claims5

Dependent claims

A cell line designated CREF-Trans 6 (ATCC Accession No. CRL 10584).

Dependencies are inferred from the claim text.

Facts

Application: 08/351,888Filed 8 Dec 1994 · continuation
Priority: 25 Oct 1990
Granted: 6 Feb 2001
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

C07K 16/28
Against material from animals or humans: against receptors, cell surface antigens or cell surface determinants
A61P 35/00
Antineoplastic agents
C07K 14/82
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: translation products from oncogenes
C07K 16/30
Against receptors, cell surface antigens or cell surface determinants: from tumour cells

Family

Application07/603,804Parent of this continuation · filed 25 Oct 1990
Application08/106,323Parent of this continuation · filed 13 Aug 1993
Application08/225,493Parent of this continuation · filed 11 Apr 1994
US 6,184,032 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results